Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on bone health and genetics. Browse all Bone & Joint Health education

Fracture risk is not just about how hard you fall. It reflects the strength and density of your bones, which are shaped over a lifetime by nutrition, activity, hormones — and a strong inherited component. Twin and family studies suggest that a large share of the variation in bone density is genetic, which helps explain why fractures can run in families.

What Determines Fracture Risk

A bone breaks when the load on it exceeds its strength. Strength depends on bone mineral density, the microscopic architecture of the bone, and how quickly bone is broken down and rebuilt through a lifelong remodeling process. Age, low estrogen or testosterone, low vitamin D and calcium, smoking, and certain medications all raise risk. Genetics sits underneath all of these, influencing peak bone mass and the rate of later bone loss.

Bone Density Is Highly Heritable

Studies of twins estimate that a majority of the differences in bone mineral density between people are inherited. Genome-wide studies have now identified hundreds of loci associated with bone density and fracture, most acting through the biology of bone-forming osteoblasts and bone-resorbing osteoclasts. No single gene dominates for most people; instead, many small effects add up, alongside a handful of higher-impact variants.

COL1A1 and the Sp1 Variant (rs1800012)

COL1A1 encodes type I collagen, the protein scaffold on which bone mineral is laid down. A classic named variant in its regulatory region, rs1800012 (the Sp1 binding-site polymorphism), has been associated in multiple studies with lower bone mineral density and increased fracture risk, particularly in the "T" allele carriers. It is a good illustration of how a change in a structural protein's gene can weaken the material properties of bone itself.

LRP5, WNT16, and the Bone-Building Pathway

The Wnt signaling pathway is a master regulator of bone formation. LRP5 is a co-receptor in this pathway: rare activating mutations cause exceptionally dense, fracture-resistant bone, while loss-of-function mutations cause fragile bone — dramatic proof of the gene's importance. Common variants near WNT16 are among the most reproducible signals for cortical bone thickness and forearm fracture risk. These genes point to the same biological lever from different angles.

VDR, Vitamin D, and Calcium Handling

The VDR gene encodes the vitamin D receptor, through which vitamin D regulates calcium absorption and bone turnover. Common VDR variants such as BsmI and FokI have been studied for their association with bone density, with modest and population-dependent effects. Because vitamin D and calcium are also modifiable through diet, sun exposure, and supplementation, VDR is a place where genetics and lifestyle clearly meet.

Reducing Fracture Risk: Evidence-Based Levers

Genes set a starting point, not a verdict. Weight-bearing and resistance exercise, adequate protein, sufficient calcium and vitamin D, not smoking, moderate alcohol, and fall-prevention strategies are all supported by evidence for protecting bone. For people at higher risk, clinicians use bone-density scanning and, when appropriate, medications. This is general context, not personal medical advice — a provider tailors it to your history.

Frequently Asked Questions About Fracture Risk and Genetics

Is fracture risk inherited?

Partly. Twin studies suggest a majority of the variation in bone mineral density is genetic, and variants in genes like COL1A1, LRP5, WNT16, and VDR influence bone strength. But nutrition, activity, hormones, and fall risk still strongly shape whether that inherited tendency leads to an actual fracture.

Which genes affect bone strength most?

COL1A1 shapes the collagen scaffold of bone, with the rs1800012 variant tied to lower density. LRP5 and WNT16 govern the Wnt bone-building pathway, and VDR influences vitamin D and calcium handling. Most people carry many small-effect variants rather than one decisive gene.

Can I lower my genetic fracture risk?

You cannot change your genes, but you can strongly influence their expression. Weight-bearing exercise, adequate protein, calcium, and vitamin D, not smoking, and fall prevention all protect bone in research. A provider can add bone-density testing and treatment when your personal risk warrants it.

Want pathway-level context on the biology behind bone strength? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — offering educational, pathway-level context about the biology discussed here, not a diagnosis or a treatment plan. Your results are a starting point for a conversation with your provider, not the end of one.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, manage, or prevent any condition. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

This article is part of the PlexusDx Education Hub. Browse all Bone & Joint Health education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.